<DOC>
	<DOCNO>NCT02733471</DOCNO>
	<brief_summary>This study evaluate efficacy safety administration lidocaine spray oesophago-gastro-duodenoscopies . Half patient receive lidocaine spray , half receive placebo .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Administering Lidocaine Spray Oesophago-gastro-duodenoscopy</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Inclusion criterion : Patients age 18 ASA I , II III Non allergic lidocaine drug use study Consent form sign patient Stomach esophagus diagnose cancer Giant hiatal hernia diagnose Zenker 's diverticulum diagnose Achalasia diagnose Patients age 70 Medical history moderate severe liver disease Medical history moderate severe renal insufficiency Medical history moderate severe Obstructive Sleep Apnea Syndrome ( OSA ) ( AHI≥15 ) . Severe respiratory insufficiency ( asmtha COPD ) diagnose Patients encephalopaty active Patients medical history methemoglobinemia Patients history drug abuse Patients mental impairment Patients BMI≥ 35 Use pediatric tube</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Lidocaine</keyword>
	<keyword>Endoscopy</keyword>
	<keyword>Tolerance</keyword>
</DOC>